Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery.

Postoperative atrial fibrillation (poAF) is the most common adverse event after cardiac surgery and is associated with increased morbidity, mortality, and increased hospital and intensive care unit length of stay. Despite progressive improvements in overall cardiac surgical operative mortality and postoperative morbidity, the incidence of poAF has remained unchanged at 30% to 50%. A number of evidence-based recommendations regarding the perioperative management of atrial fibrillation (AF) have been released from leading cardiovascular societies in recent years; however, it is unknown how closely these guidelines are being followed by medical practitioners. In addition, many of these society recommendations are based on patient stratification into "normal" and "elevated" risk groups for AF, but criteria for that stratification have not been defined clearly. In an effort to improve the perioperative management of AF, the Society of Cardiovascular Anesthesiologists (SCA) Clinical Practice Improvement Committee developed a multidisciplinary Atrial Fibrillation Working Group that created a summary of current best practices based on distillation of recent guidelines from professional societies involved in the care of cardiac surgical patients. An evidence-based set of survey questions then was generated to describe the current practice of perioperative AF management. Through a collaboration with the European Association of Cardiothoracic Anaesthetists (EACTA), that survey was distributed to the combined memberships of both the SCA and the EACTA, yielding 641 responses and resulting in the most comprehensive understanding to date of perioperative AF management in North America and Europe and beyond. The survey data demonstrated the broad range of therapies used for prevention and treatment of poAF, as well as a spectrum of adherence to published guidelines. With the goal of improving adherence, a graphical advisory tool was created with an easily accessible format that could be used for bedside management. Finally, given that no evidence-based threshold currently exists to differentiate patients at normal risk of developing poAF from those at elevated risk, the SCA/EACTA AF working group created a list of poAF risk factors using expert opinion, based on published risk score models for poAF. This allows stratification of patients into risk groups and facilitates adherence to the evidence-based recommendations summarized in the graphical advisory tool. It is the working group's hope that these new additions to the clinical toolkit for management of perioperative AF will improve the evidence-based care and outcomes of cardiac surgical patients worldwide.

[1]  K. Lunetta,et al.  Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation , 2017, Circulation.

[2]  B. Williams,et al.  Temporal Trends in the Incidence, Prevalence, and Survival of Patients With Atrial Fibrillation From 2004 to 2016. , 2017, The American journal of cardiology.

[3]  T. Schneider,et al.  Rapid onset of amiodarone induced pulmonary toxicity after lung lobe resection – A case report and review of recent literature , 2017, Annals of medicine and surgery.

[4]  Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women. , 2017, Obstetrics and gynecology.

[5]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  L. Ti,et al.  A Clinical Prediction Model for Postcardiac Surgery Atrial Fibrillation in an Asian Population , 2016, Anesthesia and analgesia.

[7]  J. Cigarroa,et al.  Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, Circulation.

[8]  M. Mack,et al.  Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery. , 2016, The New England journal of medicine.

[9]  D. Andreini,et al.  COMPUTED TOMOGRAPHY CORONARY ANGIOGRAPHY VERSUS STRESS CARDIAC MAGNETIC RESONANCE FOR THE MANAGEMENT OF SYMPTOMATIC REVASCULARIZED PATIENTS: A COST EFFECTIVENESS STUDY (STRATEGY STUDY) , 2016 .

[10]  T. Wilt,et al.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.

[11]  J. Cigarroa,et al.  Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, Journal of the American College of Cardiology.

[12]  J. Hartikainen,et al.  New-onset atrial fibrillation at discharge in patients after coronary artery bypass surgery: short- and long-term morbidity and mortality. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  G. Wells,et al.  Predicting New-Onset Postoperative Atrial Fibrillation in Cardiac Surgery Patients. , 2015, Journal of cardiothoracic and vascular anesthesia.

[14]  Grace A Lin,et al.  Preoperative medical testing in Medicare patients undergoing cataract surgery. , 2015, The New England journal of medicine.

[15]  Dan M Roden,et al.  Genetic and Clinical Risk Prediction Model for Postoperative Atrial Fibrillation , 2015, Circulation. Arrhythmia and electrophysiology.

[16]  T. Wagner,et al.  Postoperative atrial fibrillation impacts on costs and one-year clinical outcomes: the Veterans Affairs Randomized On/Off Bypass Trial. , 2015, The Annals of thoracic surgery.

[17]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[18]  Helmut Baumgartner,et al.  2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[19]  Preoperative β-blocker use in coronary artery bypass grafting surgery: national database analysis. , 2014, JAMA internal medicine.

[20]  D. Fitzmaurice,et al.  The management of atrial fibrillation: summary of updated NICE guidance , 2014, BMJ : British Medical Journal.

[21]  N. Longford,et al.  Survey of the clinical assessment and utility of near-infrared cerebral oximetry in cardiac surgery. , 2014, Journal of cardiothoracic and vascular anesthesia.

[22]  G. Angelini,et al.  Bedside Tool for Predicting the Risk of Postoperative Atrial Fibrillation After Cardiac Surgery: The POAF Score , 2014, Journal of the American Heart Association.

[23]  Kevin L. Thomas,et al.  Management of Postoperative Atrial Fibrillation and Subsequent Outcomes in Contemporary Patients Undergoing Cardiac Surgery: Insights From the Society of Thoracic Surgeons CAPS‐Care Atrial Fibrillation Registry , 2014, Clinical cardiology.

[24]  D. Mukherjee,et al.  Timing and Route of Amiodarone for Prevention of Postoperative Atrial Fibrillation after Cardiac Surgery: A Network Regression Meta‐analysis , 2013, Pacing and clinical electrophysiology : PACE.

[25]  David D. McManus,et al.  Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium , 2013, Journal of the American Heart Association.

[26]  J. Légaré,et al.  New Onset Postoperative Atrial Fibrillation is Associated with a Long‐Term Risk for Stroke and Death Following Cardiac Surgery , 2013, Journal of cardiac surgery.

[27]  Wen-tong Fang,et al.  The role of statin therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. , 2012, British journal of clinical pharmacology.

[28]  D. Arnar,et al.  Atrial fibrillation following cardiac surgery: risk analysis and long-term survival , 2012, Journal of Cardiothoracic Surgery.

[29]  T. Treasure,et al.  The development of a postoperative morbidity score to assess total morbidity burden after cardiac surgery. , 2012, Journal of clinical epidemiology.

[30]  Janet S. Wright,et al.  2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesi , 2011, Journal of the American College of Cardiology.

[31]  M. Mack,et al.  Preoperative beta-blocker usage: is it really worthy of being a quality indicator? , 2011, The Annals of thoracic surgery.

[32]  S. Johnston,et al.  Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States , 2011, Circulation. Cardiovascular quality and outcomes.

[33]  R. Damiano,et al.  The persistent problem of new-onset postoperative atrial fibrillation: a single-institution experience over two decades. , 2011, The Journal of thoracic and cardiovascular surgery.

[34]  A. Verma,et al.  Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. , 2011, The Canadian journal of cardiology.

[35]  G. Despotis,et al.  Anticoagulation management during cardiopulmonary bypass: a survey of 54 North American institutions. , 2010, The Journal of thoracic and cardiovascular surgery.

[36]  S. Body,et al.  Effect of the Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery Clinical Practice Guidelines of the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists upon Clinical Practices , 2010, Anesthesia and analgesia.

[37]  G. G. Lima,et al.  Proposta de escore de risco para predição de fibrilação atrial após cirurgia cardíaca , 2010 .

[38]  D. Delurgio,et al.  New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft. , 2010, Journal of the American College of Cardiology.

[39]  G. Lip,et al.  Atrial fibrillation following cardiac surgery: clinical features and preventative strategies. , 2008, European heart journal.

[40]  M. Banach,et al.  Atrial Fibrillation After Isolated Coronary Surgery Affects Late Survival , 2008, Circulation.

[41]  M. Mack,et al.  Atrial fibrillation after coronary artery bypass grafting surgery: development of a predictive risk algorithm. , 2007, The Annals of thoracic surgery.

[42]  Douglas K Owens,et al.  Screening Mammography for Women 40 to 49 Years of Age: A Clinical Practice Guideline from the American College of Physicians , 2007, Annals of Internal Medicine.

[43]  A. Keech,et al.  Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. , 2006, European heart journal.

[44]  Hiram A. Firpi,et al.  Prediction of Atrial Fibrillation following Cardiac Surgery using Rough Set Derived Rules , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

[45]  I. Hertz-Picciotto,et al.  Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem , 2005, Cancer Causes & Control.

[46]  K. Murray,et al.  Analysis of Cause-Specific Mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study , 2004, Circulation.

[47]  J. Mathew,et al.  A multicenter risk index for atrial fibrillation after cardiac surgery. , 2004, JAMA.

[48]  R. Villareal,et al.  Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. , 2004, Journal of the American College of Cardiology.

[49]  J. Pezzullo,et al.  Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery. , 2003, The American journal of cardiology.

[50]  R. Baranowski,et al.  Prediction of paroxysmal atrial fibrillation after aortic valve replacement in patients with aortic stenosis: identification of potential risk factors. , 2003, The Journal of heart valve disease.

[51]  W. Weintraub,et al.  Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation. , 2002, Journal of the American College of Cardiology.

[52]  C. Abendroth,et al.  Fatal pulmonary toxicity occurring within two weeks of initiation of amiodarone. , 2002, The American journal of cardiology.

[53]  N. Goldschlager,et al.  Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. , 2000, Archives of internal medicine.

[54]  M. Cabana,et al.  Why don't physicians follow clinical practice guidelines? A framework for improvement. , 1999, JAMA.

[55]  Thomas E. Moritz,et al.  Atrial fibrillation after cardiac surgery: a major morbid event? , 1997, Annals of surgery.

[56]  T O Cheng,et al.  Predictors of atrial fibrillation after coronary artery surgery. , 1997, Circulation.

[57]  L. Cohn,et al.  Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. , 1996, Circulation.

[58]  E C Rosenow,et al.  Amiodarone Pulmonary Toxicity: Recognition and Pathogenesis (Part 2) , 1988 .

[59]  E C Rosenow,et al.  Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I). , 1988, Chest.